{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:31:19Z","timestamp":1794918679699,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI046464"],"award-info":[{"award-number":["R01 AI046464"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI099125"],"award-info":[{"award-number":["R01 AI099125"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources, NIH","doi-asserted-by":"publisher","award":["C06 RR016226"],"award-info":[{"award-number":["C06 RR016226"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.vaccine.2015.10.135","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T11:40:36Z","timestamp":1447155636000},"page":"7168-7175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine"],"prefix":"10.1016","volume":"33","author":[{"given":"Serena","family":"Giuntini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Beernink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.135_bib0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/viru.26515","article-title":"Meningococcal disease and the complement system","volume":"5","author":"Lewis","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0195","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"Schneider","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0200","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/CVI.00517-14","article-title":"Heterogeneity in rhesus macaque complement factor H binding to meningococcal factor H binding protein (FHbp) informs selection of primates to assess immunogenicity of FHbp-based vaccines","volume":"21","author":"Beernink","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0205","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0210","doi-asserted-by":"crossref","first-page":"e0135996","DOI":"10.1371\/journal.pone.0135996","article-title":"A newly-identified polymorphism in rhesus macaque complement factor H modulates binding affinity for meningococcal FHbp","volume":"10","author":"Konar","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0215","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","article-title":"A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination","volume":"186","author":"Beernink","year":"2011","journal-title":"J Immun"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0220","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enchance FH binding","volume":"5","author":"Costa","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0225","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/infdis\/jiv081","article-title":"Binding of complement factor H (FH) decreases protective anti-FH binding protein antibody responses of infant rhesus macaques immunized with a meningococcal serogroup B vaccine","volume":"212","author":"Granoff","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0230","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0235","first-page":"608","article-title":"Centers for disease C. Use of serogroup B Meningococcal vaccines in persons aged >=10 years at increased risk for serogroup B Meningococcal disease: recommendations of the advisory committee on immunization practices, 2015","volume":"64","author":"Folaranmi","year":"2015","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0240","series-title":"Guide for the care and use of labortory animals","author":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2015.10.135_bib0245","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0250","doi-asserted-by":"crossref","first-page":"e00339-13","DOI":"10.1128\/mBio.00339-13","article-title":"Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis","volume":"4","author":"Lewis","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0255","doi-asserted-by":"crossref","first-page":"19716","DOI":"10.1074\/jbc.270.34.19716","article-title":"Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis","volume":"270","author":"Hourcade","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/IAI.05956-11","article-title":"Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor H binding protein","volume":"80","author":"Giuntini","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0265","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1128\/IAI.68.4.1871-1878.2000","article-title":"Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis","volume":"68","author":"Wang","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0270","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.4049\/jimmunol.160.10.5028","article-title":"Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid","volume":"160","author":"Granoff","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0275","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/IAI.05182-11","article-title":"Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding","volume":"79","author":"Giuntini","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0280","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.vaccine.2011.04.092","article-title":"Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0285","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0290","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.ppat.1001027","article-title":"The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement","volume":"6","author":"Lewis","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0295","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1128\/IAI.02984-14","article-title":"Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-FHbp bactericidal activity","volume":"83","author":"Giuntini","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0300","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00842-15","article-title":"Functional analysis of the human antibody response to meningococcal factor H binding protein","volume":"6","author":"Beernink","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0305","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/528994","article-title":"Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen","volume":"197","author":"Welsch","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0310","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0315","doi-asserted-by":"crossref","first-page":"e0128185","DOI":"10.1371\/journal.pone.0128185","article-title":"A mutant library approach to identify improved meningococcal factor H binding protein vaccine antigens","volume":"10","author":"Konar","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0320","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.vaccine.2013.08.099","article-title":"Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice","volume":"31","author":"Rossi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0325","doi-asserted-by":"crossref","first-page":"e1002688","DOI":"10.1371\/journal.ppat.1002688","article-title":"The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein","volume":"8","author":"Beernink","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0330","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0335","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5414\/CN107777","article-title":"The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies","volume":"83","author":"Kim","year":"2015","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0340","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.4049\/jimmunol.1200357","article-title":"Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor H and factor H-related protein 1 to pentraxin 3","volume":"189","author":"Kopp","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0345","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ndt\/gfp388","article-title":"Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome","volume":"25","author":"Strobel","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0350","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1200679","article-title":"Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome","volume":"189","author":"Blanc","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0355","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.1402770","article-title":"Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases","volume":"194","author":"Blanc","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.135_bib0360","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/IAI.01183-13","article-title":"Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates","volume":"82","author":"van der Veen","year":"2014","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T20:18:02Z","timestamp":1692130682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0264410X15015972"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.135","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}